Auriga Research Pvt Ltd will be participating in the China International Import Expo (CIIE) to be held at Shanghai China. Visit us at our booth at the venue, so we can have the opportunity to discuss on mutual business cooperation.
Ethics Committee Accreditation and Registration in India: Introduction
There are around 1200 registered independent and institutional ethics committees. All registered ethics committees have to go through accreditation process which was introduced recently by NABH and responsibility is assigned to quality council of India (QCI) to accredit all registered ethics committees in India. The ethics committee should review and accord its approval to a […]
DTAB recommends not using vegetarian indicator on cellulose capsules and prohibits use of PET bottles for packaging pharmaceutical drugs
In the 71st meeting of the Drugs Technical Advisory Board (DTAB) recommended that there is no need to indicate vegetarian on cellulose based capsules. They also recommended prohibiting the use PET/ plastic bottles for primary packaging of certain liquid drug formulations. At the minutes of meeting there was an agenda to consider the proposal and […]
A report by AIIH&PH on the use of PET or plastic bottles for packaging of pharmaceutical preparations, soft drinks and alcohol
Plastic bottles are used on a large scale for packaging of liquid products like water, soft drinks, cooking oils, cosmetic products like shampoo, pharmaceutical preparations and many other products. Plastic has become popular because it is lightweight, has superior resistance to breakage and relatively low production and transportation costs besides it provides ease of transportation […]
Arbro Pharma & Auriga Research Exhibiting in ASIA LABEX 2015
ASIA LABEX 2015 is a Premiere Exhibition and Conference for Analytical, Diagnostic, Laboratory, Biotechnology, Research and Testing Instruments and Consumables. Asia Labex has organized the event with the aim of bringing together professionals and stakeholders under one roof. All large and small laboratories and other testing units will have the opportunity to showcase their competencies. Delhi […]
Conference on Challenges in Design and Conduct of Clinical Trials of Medical Devices
Conference on Challenges in Design and Conduct of Clinical Trials of Medical Devices 22nd August, 2015 (Saturday) Venue – Jamia Hamdard, Convention Center, Delhi Timing – 8:30 am to 5:30 pm Chief Guest: Dr. S. Eswara Reddy, Joint Drugs Controller (India), CDSCO Medical device is a 1 trillion US dollars market all over the world. Though we have […]
Great News! Auriga BE Center is now approved by NPCB, Malaysia
We are excited to share with you that our Bioequivalence (BE) center has been approved by NPCB (National Pharmaceutical Control Bureau), Ministry of Health Malaysia. We are one of only five BE centers in India having approval from NPCB, Malaysia. Here is the link of their website with details of approval. http://portal.bpfk.gov.my/index.cfm?&menuid=31&parentid=82&highlightid=78 As Malaysia is […]
Conference on Accreditation of Sites, Investigators and Ethics Committees
Conference on Accreditation of Sites, Investigators and Ethics Committees – 17th Apr 2015 Workshop on Causality Assessment for Clinical Trials in the Indian Scenario – 18th Apr 2015 Venue – Hotel Royal Orchid Central, Gurgaon Timing – 9:00 am to 5:00 pm (Both the days) In the last 3 years, the Clinical Research industry of […]
Free e-Course : Regulation on Medical Devices and Diagnostic Kits in India
Regulatory Authority that governs the regulations of Registration and Import of medical devices in India is Drugs Controller General (India), Central Drugs Standard Control Organization (CDSCO), Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India , FDA Bhavan, ITO, Kotla Road, New Delhi -110002 Phone: 91-11-23236965 / 23236975, Fax: 91-11-23236973, […]
Webinar on Clinical Trial Insurance in Current Perspective of Compensation Requirements in India
Reserve your spot now! Wednesday, June 25, 2014 @ 3:00 PM IST New compensation guideline for clinical trial participants in case of death and injury has been introduced after recent amendment in schedule Y (Rule 122DAB – Compensation in case of injury or death during clinical trial). Formula to Determine the quantum of compensation in […]